CN Stock MarketDetailed Quotes

300529 Jafron Biomedical

Watchlist
  • 28.82
  • +0.17+0.59%
Market Closed Jul 12 15:00 CST
23.27BMarket Cap44.34P/E (TTM)

Jafron Biomedical Key Stats

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
30.00%744.34M
-22.84%1.92B
-26.64%1.49B
-34.88%1.01B
-17.90%572.56M
-6.88%2.49B
13.69%2.03B
30.80%1.55B
20.46%697.36M
37.15%2.68B
Operating revenue
30.00%744.34M
-22.84%1.92B
-26.64%1.49B
-34.88%1.01B
-17.90%572.56M
-6.88%2.49B
13.69%2.03B
30.80%1.55B
20.46%697.36M
37.15%2.68B
Other operating revenue
----
-24.74%3.42M
----
29.57%1.4M
----
0.93%4.54M
----
-13.68%1.08M
----
-3.04%4.5M
Total operating cost
20.39%421.94M
-8.35%1.42B
-4.87%1.01B
-3.00%705.76M
11.51%350.49M
16.29%1.55B
29.75%1.07B
46.81%727.58M
25.11%314.32M
39.17%1.33B
Operating cost
41.52%158.66M
-12.75%383.98M
-15.14%287.35M
-21.85%196.86M
3.74%112.11M
9.46%440.11M
26.28%338.6M
43.93%251.89M
26.36%108.06M
39.62%402.06M
Operating tax surcharges
37.04%11.67M
-9.28%31.82M
-17.71%23.41M
-29.58%15.71M
-22.55%8.51M
-12.41%35.07M
6.97%28.45M
26.51%22.3M
28.13%10.99M
39.50%40.04M
Operating expense
1.00%158.5M
-12.08%615.97M
-4.46%441.05M
6.31%323.58M
26.13%156.94M
17.07%700.63M
26.14%461.66M
38.80%304.37M
10.08%124.43M
27.76%598.49M
Administration expense
39.32%38.47M
28.40%177.39M
22.60%112.65M
16.30%72.91M
-5.14%27.61M
5.48%138.15M
13.88%91.88M
34.02%62.69M
7.05%29.11M
10.05%130.97M
Financial expense
105.47%476.36K
-90.21%-33.9M
-57.89%-26.85M
-32.70%-17.91M
-1,009.28%-8.71M
-43.27%-17.82M
-6.02%-17M
5.41%-13.5M
123.95%957.75K
54.20%-12.44M
-Interest expense (Financial expense)
33.49%16.35M
50.74%54.33M
171.94%40.29M
156.73%25.23M
151.53%12.25M
304.60%36.04M
246.51%14.82M
3,060.84%9.83M
--4.87M
--8.91M
-Interest Income (Financial expense)
27.08%-15.65M
-65.15%-87.96M
-77.87%-67M
-62.99%-43.41M
-247.18%-21.46M
-91.63%-53.26M
-84.07%-37.67M
-70.16%-26.63M
-29.11%-6.18M
3.55%-27.79M
Research and development
0.27%54.17M
-3.36%245.38M
8.67%176.36M
14.82%114.62M
32.50%54.02M
46.12%253.91M
68.86%162.28M
95.09%99.82M
95.03%40.77M
115.17%173.77M
Credit Impairment Loss
-264.19%-1.28M
320.33%8.23M
130.26%2.45M
151.83%3.97M
115.65%777.07K
130.33%1.96M
-4.30%-8.09M
-52.12%-7.66M
-12.87%-4.97M
-240.68%-6.46M
Asset Impairment Loss
--0
-332.78%-28.18M
--0
--0
--0
-11,345.79%-6.51M
--0
--0
--0
-49.68%-56.89K
Other net revenue
53.85%26.32M
-52.18%42.11M
-30.19%43.12M
-37.89%33.14M
59.40%17.11M
16.84%88.06M
15.11%61.76M
37.78%53.35M
52.34%10.73M
22.98%75.37M
Fair value change income
--1.01M
--0
--0
--0
--0
-200.00%-14.99K
---14.99K
---14.99K
---14.99K
--14.99K
Invest income
--2.53M
--0
--0
--0
--0
-63.34%10.52M
-39.61%10.48M
-22.32%9.66M
36.80%10.69M
88.92%28.7M
Asset deal income
-76.75%1.28M
677.04%6.72M
1,039.72%5.92M
1,268.35%6.06M
2,659.55%5.5M
-12.01%864.77K
-7.14%519.06K
43.18%442.64K
--199.14K
--982.81K
Other revenue
110.20%22.78M
-31.87%55.35M
-40.97%34.76M
-54.62%23.11M
124.41%10.83M
55.69%81.24M
35.33%58.88M
64.18%50.93M
32.90%4.83M
8.65%52.18M
Operating profit
45.80%348.72M
-47.17%543.82M
-49.58%515.13M
-61.42%339.52M
-39.26%239.18M
-27.40%1.03B
0.75%1.02B
20.33%880.06M
17.64%393.77M
34.48%1.42B
Add:Non operating Income
-62.65%62.17K
-13.26%322.34K
56.21%319.56K
81.86%246.02K
288.79%166.45K
-51.91%371.63K
-70.00%204.58K
-74.35%135.28K
-68.97%42.81K
49.26%772.73K
Less:Non operating expense
15.36%8.84M
77.61%23.12M
184.17%16.56M
256.16%10.71M
1,072.82%7.67M
13.41%13.02M
-4.07%5.83M
12.70%3.01M
71.24%653.73K
-49.92%11.48M
Total profit
46.73%339.93M
-48.76%521.02M
-50.90%498.89M
-62.49%329.06M
-41.07%231.68M
-27.74%1.02B
0.73%1.02B
20.29%877.19M
17.54%393.16M
36.37%1.41B
Less:Income tax cost
53.74%56.01M
-29.86%95.3M
-46.58%78.45M
-58.94%53.86M
-38.01%36.43M
-35.72%135.86M
0.24%146.87M
19.06%131.18M
13.69%58.77M
32.98%211.38M
Net profit
45.42%283.93M
-51.67%425.72M
-51.62%420.44M
-63.11%275.2M
-41.61%195.25M
-26.33%880.95M
0.82%869.1M
20.51%746.01M
18.25%334.39M
36.98%1.2B
Net profit from continuing operation
45.42%283.93M
-51.67%425.72M
-51.62%420.44M
-63.11%275.2M
-41.61%195.25M
-26.33%880.95M
0.82%869.1M
20.51%746.01M
18.25%334.39M
36.98%1.2B
Less:Minority Profit
34.49%-837.96K
-24.94%-10.77M
25.96%-3.22M
-7.31%-2.31M
-56.54%-1.28M
-786.84%-8.62M
-325.93%-4.35M
-97.33%-2.15M
-56.68%-817.14K
56.69%-971.91K
Net profit of parent company owners
44.90%284.77M
-50.93%436.49M
-51.50%423.66M
-62.91%277.51M
-41.37%196.53M
-25.67%889.56M
1.20%873.45M
20.64%748.16M
18.32%335.21M
36.74%1.2B
Earning per share
Basic earning per share
42.76%0.3512
-50.89%0.55
-51.82%0.53
-62.37%0.35
-41.43%0.246
-24.83%1.12
1.85%1.1
19.23%0.93
20.00%0.42
35.45%1.49
Diluted earning per share
44.00%0.3495
-49.56%0.57
-51.85%0.52
-63.44%0.34
-40.80%0.2427
-24.16%1.13
0.93%1.08
20.78%0.93
17.14%0.41
37.96%1.49
Other composite income
181.20%26.93M
0
0
-3,304.61%-33.17M
1.81M
1.81M
0
167.54%1.03M
Other composite income of parent company owners
----
181.20%26.93M
--0
--0
----
-3,304.61%-33.17M
--1.81M
--1.81M
--0
167.54%1.03M
Total composite income
45.42%283.93M
-46.61%452.65M
-51.72%420.44M
-63.20%275.2M
-41.61%195.25M
-29.17%847.78M
1.03%870.91M
20.80%747.82M
18.25%334.39M
37.34%1.2B
Total composite income of parent company owners
44.90%284.77M
-45.89%463.42M
-51.60%423.66M
-63.00%277.51M
-41.37%196.53M
-28.51%856.4M
1.41%875.26M
20.93%749.97M
18.32%335.21M
37.10%1.2B
Total composite income of minority owners
34.49%-837.96K
-24.94%-10.77M
25.96%-3.22M
-7.31%-2.31M
-56.54%-1.28M
-786.84%-8.62M
-325.93%-4.35M
-97.33%-2.15M
-56.68%-817.14K
56.69%-971.91K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Grant Tung Certified Public Accountants (Special General Partnership)
--
--
--
Grant Tung Certified Public Accountants (Special General Partnership)
--
--
--
Grant Tung Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 30.00%744.34M-22.84%1.92B-26.64%1.49B-34.88%1.01B-17.90%572.56M-6.88%2.49B13.69%2.03B30.80%1.55B20.46%697.36M37.15%2.68B
Operating revenue 30.00%744.34M-22.84%1.92B-26.64%1.49B-34.88%1.01B-17.90%572.56M-6.88%2.49B13.69%2.03B30.80%1.55B20.46%697.36M37.15%2.68B
Other operating revenue -----24.74%3.42M----29.57%1.4M----0.93%4.54M-----13.68%1.08M-----3.04%4.5M
Total operating cost 20.39%421.94M-8.35%1.42B-4.87%1.01B-3.00%705.76M11.51%350.49M16.29%1.55B29.75%1.07B46.81%727.58M25.11%314.32M39.17%1.33B
Operating cost 41.52%158.66M-12.75%383.98M-15.14%287.35M-21.85%196.86M3.74%112.11M9.46%440.11M26.28%338.6M43.93%251.89M26.36%108.06M39.62%402.06M
Operating tax surcharges 37.04%11.67M-9.28%31.82M-17.71%23.41M-29.58%15.71M-22.55%8.51M-12.41%35.07M6.97%28.45M26.51%22.3M28.13%10.99M39.50%40.04M
Operating expense 1.00%158.5M-12.08%615.97M-4.46%441.05M6.31%323.58M26.13%156.94M17.07%700.63M26.14%461.66M38.80%304.37M10.08%124.43M27.76%598.49M
Administration expense 39.32%38.47M28.40%177.39M22.60%112.65M16.30%72.91M-5.14%27.61M5.48%138.15M13.88%91.88M34.02%62.69M7.05%29.11M10.05%130.97M
Financial expense 105.47%476.36K-90.21%-33.9M-57.89%-26.85M-32.70%-17.91M-1,009.28%-8.71M-43.27%-17.82M-6.02%-17M5.41%-13.5M123.95%957.75K54.20%-12.44M
-Interest expense (Financial expense) 33.49%16.35M50.74%54.33M171.94%40.29M156.73%25.23M151.53%12.25M304.60%36.04M246.51%14.82M3,060.84%9.83M--4.87M--8.91M
-Interest Income (Financial expense) 27.08%-15.65M-65.15%-87.96M-77.87%-67M-62.99%-43.41M-247.18%-21.46M-91.63%-53.26M-84.07%-37.67M-70.16%-26.63M-29.11%-6.18M3.55%-27.79M
Research and development 0.27%54.17M-3.36%245.38M8.67%176.36M14.82%114.62M32.50%54.02M46.12%253.91M68.86%162.28M95.09%99.82M95.03%40.77M115.17%173.77M
Credit Impairment Loss -264.19%-1.28M320.33%8.23M130.26%2.45M151.83%3.97M115.65%777.07K130.33%1.96M-4.30%-8.09M-52.12%-7.66M-12.87%-4.97M-240.68%-6.46M
Asset Impairment Loss --0-332.78%-28.18M--0--0--0-11,345.79%-6.51M--0--0--0-49.68%-56.89K
Other net revenue 53.85%26.32M-52.18%42.11M-30.19%43.12M-37.89%33.14M59.40%17.11M16.84%88.06M15.11%61.76M37.78%53.35M52.34%10.73M22.98%75.37M
Fair value change income --1.01M--0--0--0--0-200.00%-14.99K---14.99K---14.99K---14.99K--14.99K
Invest income --2.53M--0--0--0--0-63.34%10.52M-39.61%10.48M-22.32%9.66M36.80%10.69M88.92%28.7M
Asset deal income -76.75%1.28M677.04%6.72M1,039.72%5.92M1,268.35%6.06M2,659.55%5.5M-12.01%864.77K-7.14%519.06K43.18%442.64K--199.14K--982.81K
Other revenue 110.20%22.78M-31.87%55.35M-40.97%34.76M-54.62%23.11M124.41%10.83M55.69%81.24M35.33%58.88M64.18%50.93M32.90%4.83M8.65%52.18M
Operating profit 45.80%348.72M-47.17%543.82M-49.58%515.13M-61.42%339.52M-39.26%239.18M-27.40%1.03B0.75%1.02B20.33%880.06M17.64%393.77M34.48%1.42B
Add:Non operating Income -62.65%62.17K-13.26%322.34K56.21%319.56K81.86%246.02K288.79%166.45K-51.91%371.63K-70.00%204.58K-74.35%135.28K-68.97%42.81K49.26%772.73K
Less:Non operating expense 15.36%8.84M77.61%23.12M184.17%16.56M256.16%10.71M1,072.82%7.67M13.41%13.02M-4.07%5.83M12.70%3.01M71.24%653.73K-49.92%11.48M
Total profit 46.73%339.93M-48.76%521.02M-50.90%498.89M-62.49%329.06M-41.07%231.68M-27.74%1.02B0.73%1.02B20.29%877.19M17.54%393.16M36.37%1.41B
Less:Income tax cost 53.74%56.01M-29.86%95.3M-46.58%78.45M-58.94%53.86M-38.01%36.43M-35.72%135.86M0.24%146.87M19.06%131.18M13.69%58.77M32.98%211.38M
Net profit 45.42%283.93M-51.67%425.72M-51.62%420.44M-63.11%275.2M-41.61%195.25M-26.33%880.95M0.82%869.1M20.51%746.01M18.25%334.39M36.98%1.2B
Net profit from continuing operation 45.42%283.93M-51.67%425.72M-51.62%420.44M-63.11%275.2M-41.61%195.25M-26.33%880.95M0.82%869.1M20.51%746.01M18.25%334.39M36.98%1.2B
Less:Minority Profit 34.49%-837.96K-24.94%-10.77M25.96%-3.22M-7.31%-2.31M-56.54%-1.28M-786.84%-8.62M-325.93%-4.35M-97.33%-2.15M-56.68%-817.14K56.69%-971.91K
Net profit of parent company owners 44.90%284.77M-50.93%436.49M-51.50%423.66M-62.91%277.51M-41.37%196.53M-25.67%889.56M1.20%873.45M20.64%748.16M18.32%335.21M36.74%1.2B
Earning per share
Basic earning per share 42.76%0.3512-50.89%0.55-51.82%0.53-62.37%0.35-41.43%0.246-24.83%1.121.85%1.119.23%0.9320.00%0.4235.45%1.49
Diluted earning per share 44.00%0.3495-49.56%0.57-51.85%0.52-63.44%0.34-40.80%0.2427-24.16%1.130.93%1.0820.78%0.9317.14%0.4137.96%1.49
Other composite income 181.20%26.93M00-3,304.61%-33.17M1.81M1.81M0167.54%1.03M
Other composite income of parent company owners ----181.20%26.93M--0--0-----3,304.61%-33.17M--1.81M--1.81M--0167.54%1.03M
Total composite income 45.42%283.93M-46.61%452.65M-51.72%420.44M-63.20%275.2M-41.61%195.25M-29.17%847.78M1.03%870.91M20.80%747.82M18.25%334.39M37.34%1.2B
Total composite income of parent company owners 44.90%284.77M-45.89%463.42M-51.60%423.66M-63.00%277.51M-41.37%196.53M-28.51%856.4M1.41%875.26M20.93%749.97M18.32%335.21M37.10%1.2B
Total composite income of minority owners 34.49%-837.96K-24.94%-10.77M25.96%-3.22M-7.31%-2.31M-56.54%-1.28M-786.84%-8.62M-325.93%-4.35M-97.33%-2.15M-56.68%-817.14K56.69%-971.91K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Grant Tung Certified Public Accountants (Special General Partnership)------Grant Tung Certified Public Accountants (Special General Partnership)------Grant Tung Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg